American Society of Hematology Annual Meeting (ASH)

December 7-9 | Orlando, FL

SHYFT will be attending the 61st ASH (American Society of Hematology) annual meeting as part of the Acorn AI, a Medidata Company. ASH, the second largest Oncology event following ASCO, brings together more than 20,000 hematologists and other healthcare professionals from all 50 states and more than 100 countries in the world. With over 18K clinical trials conducted, comprised of 5.2 million patients, Medidata is uniquely positioned to bring actionable insights to the frontlines of decision-making in dozens of indications, including MM and AML. Visit booth #2461 to learn more about Medidata’s experience and expertise in Hematology and Oncology and join our poster session (publication #3599) on the evening of Monday, Dec. 9 to learn more about the first use of proteomics data to study early indicators of treatment response in Castleman’s disease.

Click here to learn more about our presence at ASH.